Lincoln Pharmaceuticals Ltd Annually Results

Gross Sales

580.55

510.31

472.12

424.19

386.49

Excise Duty

0

0

0

0

0

Net Sales

580.55

510.31

472.12

424.19

386.49

Other Operating Income

0

0

0

0

0

Other Income

34.42

22.47

10

5.66

11.04

Total Income

614.97

532.78

482.12

429.85

397.53

Total Expenditure

480.64

421.11

376.64

337.01

320.95

PBIDT

134.33

111.68

105.48

92.84

76.58

Interest

1.46

2.03

1.45

1.56

2.02

PBDT

132.87

109.65

104.03

91.28

74.56

Depreciation

10.62

9.17

8.09

7.56

7.33

Minority Interest Before NP

0

0

0

0

0

Tax

25.44

25.99

25.86

21.22

15.73

Deferred Tax

3.49

1.59

0.72

0.25

0.04

Reported Profit After Tax

93.3

72.9

69.36

62.25

51.47

Minority Interest After NP

0

0

0

0

0.03

Net Profit after Minority Interest

93.3

72.9

69.36

62.25

51.44

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

93.3

72.9

69.36

62.25

51.44

EPS (Unit Curr.)

46.58

36.4

34.63

31.07

25.72

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

18

15

15

15

15

Equity

20.03

20.03

20.03

20.03

20

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

23.13

21.88

22.34

21.88

19.81

PBDTM(%)

22.88

21.48

22.03

21.51

19.29

PATM(%)

16.07

14.28

14.69

14.67

13.31